Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the appointment of Aaron ...

The healthcare technology space is gaining enormous investors' attention these days, thanks to the rapid advancements in artificial intelligence (AI) in this niche. Companies like Tempus AI TEM are ...

Genetics Home Reference. Ambry Genetics. How are direct-to-consumer and medical-grade genetic tests different? U.S. National Library of Medicine. What is the cost of genetic testing, and how long does ...

The United States genetic testing market is poised for substantial growth, projected to expand from USD 4.71 billion in 2021 to approximately USD 12.08 billion by 2028, with a robust CAGR of 14.50%.

Tempus "increased" its 2025 revenue guidance from $1.23 billion to $1.24 billion (for the consolidated Tempus and Ambry Genetics business), with adjusted EBITDA of “approximately $5 million.” ...

Genetic diversity is a crucial indicator for the conservation of germplasm resources. Studies have revealed that the Huang-Huai goat, along with several other local breeds such as the Funiu white goat ...

This genetic reunion, occurring roughly 300,000 years ago, resulted in one group contributing 80% of modern human DNA, while the other provided the remaining 20%. These findings suggest human ...

Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark broader industry growth?

Management guides for $1.24 billion in 2025 revenues, a 79% YoY growth, bolstered by the Ambry Genetics acquisition and a rapidly growing TAM. Despite the deep selloff recently, I rank TEM a ...

Modern humans descended from not one, but at least two ancestral populations that drifted apart and later reconnected, long before modern humans spread across the globe. Using advanced analysis ...